Klaus Früh, Ph.D.

Klaus Früh, Ph.D.

Credit: OHSU News

Klaus Früh, Ph.D., professor in OHSU’s Vaccine & Gene Therapy Institute, investigates the potential of cytomegalovirus-based vaccines. With colleagues Louis Picker, M.D., and Scott Hansen, Ph.D., both in VGTI, they have found their vaccine platform shows promise as a “shield” against cancer. (OHSU/Christine Torres Hicks)

Download Photo (16.1 MB)

Facebook Twitter LinkedIn YouTube Instagram OHSU Braille services OHSU sign language services OHSU interpreter services X